In his visit to the White House next month, Anthony Albanese is expected to come under pressure to weaken the Pharmaceutical Benefits Scheme that Donald Trump considers unfair to American drug companies.
It has taken 13 years of advocacy to develop the new national code to address gender-based violence on campus and make universities accountable for the safety of students.
While advocates say they have been ambushed by Labor’s plans to eject autistic children from the National Disability Insurance Scheme, the agency has been accused of ignoring multiple legal orders.
Despite the government’s pre-election commitment to women’s health and making HRT more accessible, ongoing shortages are sparking questions about equity in healthcare.
US senators are siding with the country’s drug industry to demand that trade deals attack subsidies such as Australia’s scheme, a letter to the administration reveals.
Some of Australia’s most popular sunscreens have been exposed for failing to provide the advertised protection – and this in turn has revealed shortcomings in lab testing.
A report showing increased smoking and vaping among young Australians was pulled after it embarrassed the government and led to complaints from other researchers.
The NDIS has opened up the world for so many people living with disability. Many fear the newly introduced restrictions and more onerous reporting could again limit lives.
A new twice-yearly antiviral injection that can prevent HIV is likely to be approved soon in Australia. Making it affordable will be the next challenge.
